Breakfast Interactive Session on “Drug Discovery – a Historical Perspective and Role of Public Private Partnerships” At Hyatt Regency on Friday, January 30, 2015

AMCHAM Eastern Chapter organized an interactive session on “Drug Discovery – a Historical Perspective and Role of Public Private Partnerships” on 30th January, 2015 at the Hyatt Regency, Kolkata. Mr. Swapan Bhattacharya, Managing Director TCG Life sciences, was the Keynote Speaker.

 

Ms. Amada Kidwai, Regional Directory, AMCHAM Eastern India started the proceedings and introduced the guests on the dais. Mr. Suranjan Bhanja, Chairman, AMCHAM Eastern Chapter in his welcome address spoke highly of Mr. Bhattacharya the key note speaker.

 

 He also elaborated on the growing need for substantial development in the field of drug discovery.  Ms. Helen Lafave, U.S. Consul General in Kolkata who is the Guest of Honour, spoke at length about the importance of the evolution of the drug industry and its importance in modern times.

 

Healthcare has been a critical area of importance for the US Government and drug discovery is an integral part of the same.

 

 Mr. Bhattacharya spoke about the advances in drug development over the past few decades.  He mentioned about the various momentous innovations in technology as well as in the types of drugs discovered.   He elaborated the importance of India as a key destination for research and development in this area which had pushed fort with drug discoveries despite limitations of resources of capital and manpower.

 

He spoke on the importance of biology being the driving factor in this century toward discovery of various fields especially in steam cell treatment which he said is still under trail stage.   He went on to mention that integrated research and development capabilities from early biology to clinical research would enhance the entire pharmaceutical value chain.

This would also enabled academic institutions and start-up venture companies to play a more critical role in the discovery of new therapies.

 

He concluded by saying that while India has made valuable contributions in generic drug innovation, even changes in its IP laws, it had not ushered increased investment in new drug discovery research.

 Mr. Dinesh Agarwal, Vice Chairman Amcham Eastern Chapter moderated the Q&A session and gave the concluding remarks. While he recounted the essential takeaways from the session, Mr. Agarwal also mentioned about the essential role the industry plays.